case | 14 Nov 2014
Setterwalls advised Recipharm in connection with SEK 1 billion acquisition of Lusomedicameta
![Responsive image](https://setterwalls.se/wp-content/uploads/2021/10/setterwalls_kompetens_aktiemarknadsratt_0-1-1200x500.jpg)
Setterwalls was the legal advisor for Recipharm AB (publ) in connection with the SEK 1 billion acquisition of Lusomedicameta Sociedade Técnica Farmacêutica S.A., a Lisbon based CDMO company. The equity consideration has been paid in a combination of cash and new issued shares.